Famitinib
HR-FMTN- Ⅱ-NSCLC-MON
Phase 2 small_molecule on_hold
Quick answer
Famitinib for Non-Small Cell Lung Cancer (NSCLC) is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Non-Small Cell Lung Cancer (NSCLC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- on_hold